References
- Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol. 1980;106:772–776.
- Zanetti D, Di Berardino F, Nassif N. Intratympanic steroid delivery by an indwelling catheter in refractory severe sudden sensorineural hearing loss. Auris Nasus Larynx. 2018;45(2):227–233. [cited 2017 Oct 16]; Available from: http://linkinghub.elsevier.com/retrieve/pii/S0385814617300974.
- Qiang Q, Wu X, Yang T, et al. A comparison between systemic and intratympanic steroid therapies as initial therapy for idiopathic sudden sensorineural hearing loss: a meta-analysis. Acta Otolaryngol. 2017;137:598–605.
- van Wijck F, Staecker H, Lefebvre PP. Topical steroid therapy using the Silverstein MicrowickTM in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol. 2007;127:1012–1017.
- Bowe SN, Jacob A. Round window perfusion dynamics: implications for intracochlear therapy. Curr Opin Otolaryngol Head Neck Surg. 2010;18:377–385.
- Robey AB, Morrow T, Moore GF. Systemic side effects of transtympanic steroids. Laryngoscope. 2010;120:S217.
- Silverstein H. Use of a new device, the MicroWick, to deliver medication to the inner ear. Ear Nose Throat J. 1999;78:595–598.
- Yoo MH, Lim WS, Park JH, et al. Simultaneous versus sequential intratympanic steroid treatment for severe-to-profound sudden sensorineural hearing loss. Audiol Neurotol. 2016;21:399–405.
- Barriat S, van Wijck F, Staecker H, et al. Intratympanic steroid therapy using the Silverstein MicrowickTM for refractory sudden sensorineural hearing loss increases speech intelligibility. Audiol Neurotol. 2012;17:105–111.
- Kang WS, Yang CJ, Shim M, et al. Prognostic factors for recovery from sudden sensorineural hearing loss: a retrospective study. J Audiol Otol. 2017;21:9–15.
- Hoffmann KK, Silverstein H. Inner ear perfusion: indications and applications. Curr Opin Otolaryngol Head Neck Surg. 2003;11:334–339.
- Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109:1–17.
- Ermutlu G, Süslü N, Yılmaz T, et al. Sudden hearing loss: an effectivity comparison of intratympanic and systemic steroid treatments. Eur Arch Oto-Rhino-Laryngology. 2017; 274(10):3585–3591.
- Gianoli GJ, Li JC. Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Neck Surg. 2001;125:142–146.
- Chou Y-F, Chen P-R, Kuo I-J, et al. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss. Laryngoscope. 2013;123:2264–2269.
- Salt AN, Hartsock JJ, Gill RM, et al. Perilymph pharmacokinetics of markers and dexamethasone applied and sampled at the lateral semi-circular canal. Jaro. 2012;13:771–783.
- Filipo R, Attanasio G, Russo FY, et al. Intratympanic steroid therapy in moderate sudden hearing loss: a randomized, triple-blind, placebo-controlled trial. Laryngoscope. 2013;123:774–778.
- Hu A, Parnes LS. Intratympanic steroids for inner ear disorders: a review. Audiol Neurotol. 2009;14:373–382.